What’s Next for U.S. Healthcare Under Trump?
- VOLUME XVIII, ISSUE 46
- Executive Insights
What will the transition to a Trump administration mean for the healthcare industry’s key constituents? While experts of all stripes are asserting predictions, they are typically long on speculation and short on evidence.
At this stage, there are still far more unknowns than knowns. How much of the GOP healthcare agenda will the Trump administration adopt? What will be the openness to traditionally powerful lobbying groups, such as the AHA, AMA, AHIP and Big Pharma? Most important, what will be the focus and cadence of change efforts to come?
In a moment of political uncertainty, it is most useful to know which issues and stakeholder “tensions” to watch closely. In this Executive Insights, we: